Acquired haemophilia A (AHA) is caused by autoantibodies that neutralise Factor VIII (FVIII) and can cause severe bleeding. The COVID-19 vaccine may trigger the development of acquired autoantibodies ...

Medically reviewed by Steffini Stalos, DO Hemophilia disease is a rare inherited bleeding disorder. People with this genetic ...

This infographic explores the role of gene therapy in treating haemophilia, focusing specifically on haemophilia A and B. It ...

The City of College Station issued a proclamation just in time for National Bleeding Disorders Awareness Month.

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...

Hemophilia treatment market is driven by aging populations increasing acquired cases, government-backed early diagnosis, and ...

Hemophilia is a serious condition that can limit the ability to avoid episodes of bleeding. Treatment includes regular infusions of proteins to replace what the body doesn’t produce naturally.

Treatment involved an antithrombin-based dose regimen targeting antithrombin levels between 15% and 35%, starting at 50 mg ...

Columnist G. Shellye Horowitz chats with Hannes Jung, creator of the Bleeder app, which helps hemophilia patients track ...

At an international conference, columnist G Shellye Horowitz has a bleed that spurs questions about how women with hemophilia ...

The hemophilia treatment landscape is rapidly evolving, with newly launched therapies and gene therapies joining factor replacement therapies, Hemlibra, and Altuvio to ...